Today(December 8), Shiseido Company has announced the launch of Shiseido Long Term Investments for the Future (LIFT) Ventures, a newly formed limited liability company.
It is stated that LIFT Ventures will serve as a platform for investing in innovative early-stage companies operating within the beauty wellness sector. The primary focus of LIFT Ventures will be to invest in novel technologies, innovative platforms, high-growth brands, and new business models, among other areas of interest. This dedicated fund aligns with Shiseido’s vision of becoming a personal beauty wellness company. While maintaining a global perspective, the fund will primarily seek compelling innovation in the Western hemisphere.
In conjunction with this announcement, Shiseido has revealed the fund’s inaugural investments in two companies. The first is Phi Therapeutics, Inc. (“Phyla”), a pioneer in bacteriophage technology based in San Francisco, California. The second investment is in Patrick Kidd Holdings Pty Ltd. (“Patricks”), a men’s grooming brand with an elevated lifestyle approach based in Sydney, Australia. Phyla was founded by Yug Varma, PhD, while Patricks was founded by Patrick and Aimee Kidd.
Masahiko Uotani, Chairman and CEO of Shiseido, sees the creation of LIFT Ventures as an opportunity to collaborate with organizations dedicated to developing pioneering beauty wellness solutions, gaining valuable insights, and fostering Shiseido’s growth ambitions. Uotani believes that LIFT Ventures will facilitate knowledge-building, value creation, and significant progress for all involved.
Ron Gee, President and CEO of Shiseido Americas, expressed that LIFT Ventures will accelerate the company’s focus on innovation, serving as a natural extension of their commitment to shaping the future of beauty and wellness. He is delighted to partner with Phyla and Patricks, two companies dedicated to driving innovation and disrupting their respective categories.
Ron Gee will lead LIFT Ventures, which will be headquartered in New York City.
